| representation,harmonization_standard,variation_type,semantic_type,source_terminology | |
| "1,3-Beta-D-Glucan Measurement","1,3-Beta-D-Glucan Measurement",standard,Laboratory Procedure,NCIt | |
| "1,5-Anhydroglucitol","1,5-Anhydroglucitol Measurement",synonym,Laboratory Procedure,NCIt | |
| 10p13-p14 Deletion Syndrome,10p13-p14 Deletion Syndrome,standard,Disease or Syndrome,NCIt | |
| 11-Dehydrothromboxane B2 Excretion Rate,11-Dehydro-Thromboxane B2 Excretion Rate,synonym,Laboratory Procedure,NCIt | |
| 11-Dehydro-Thromboxane B2 Measurement,11-Dehydro-Thromboxane B2 Measurement,standard,Laboratory Procedure,NCIt | |
| 11-Ketoetiocholanolone,11-Ketoetiocholanolone Measurement,synonym,Laboratory Procedure,NCIt | |
| 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency,17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency,standard,Disease or Syndrome,NCIt | |
| 17-Ketogenic steroids,17-Ketogenic Steroid Measurement,synonym,Laboratory Procedure,NCIt | |
| 18-Hydroxycortisol Measurement,18-Hydroxycortisol Measurement,standard,Laboratory Procedure,NCIt | |
| 2-5-Oligoadenylate Synthase 1,2-5-Oligoadenylate Synthase 1 Measurement,synonym,Laboratory Procedure,NCIt | |
| 2-5-Oligoadenylate Synthase 2 Measurement,2-5-Oligoadenylate Synthase 2 Measurement,standard,Laboratory Procedure,NCIt | |
| 2-5-Oligoadenylate Synthase 3,2-5-Oligoadenylate Synthase 3 Measurement,synonym,Laboratory Procedure,NCIt | |
| 21-Deoxycorticosterone Measurement,21-Deoxycorticosterone Measurement,standard,Laboratory Procedure,NCIt | |
| 22(R)-Hydroxycholesterol,22(R)-Hydroxycholesterol Measurement,synonym,Laboratory Procedure,NCIt | |
| 22q11.2 Deletion Syndrome,22q11.2 Deletion Syndrome,standard,Disease or Syndrome,NCIt | |
| "24(S),25-Epoxycholesterol","24(S),25-Epoxycholesterol Measurement",synonym,Laboratory Procedure,NCIt | |
| 24(S)-Hydroxycholesterol Measurement,24(S)-Hydroxycholesterol Measurement,standard,Laboratory Procedure,NCIt | |
| "24,25-Dihydroxyvitamin D","24,25-Dihydroxyvitamin D3 Measurement",synonym,Laboratory Procedure,NCIt | |
| 25-Hydroxyvitamin D2 Measurement,25-Hydroxyvitamin D2 Measurement,standard,Laboratory Procedure,NCIt | |
| 25-Hydroxyvit D2 + 25-Hydroxyvit D3,25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement,synonym,Laboratory Procedure,NCIt | |
| 25-Hydroxyvitamin D3 Measurement,25-Hydroxyvitamin D3 Measurement,standard,Laboratory Procedure,NCIt | |
| 28S to 18S Ribosomal RNA Ratio,28S Ribosomal RNA to 18S Ribosomal RNA Ratio,synonym,Laboratory Procedure,NCIt | |
| "3,4-Methylenedioxyethamphetamine Measurement","3,4-Methylenedioxyethamphetamine Measurement",standard,Laboratory Procedure,NCIt | |
| "3,4-methylenedioxy-N-ethylamphetamine","3,4-methylenedioxy-N-ethylamphetamine Measurement",synonym,Laboratory Procedure,NCIt | |
| 3-Log Reduction in Ph+ Cells,3-Log Reduction in Ph+ Cells,standard,Finding,NCIt | |
| 3-Methylglutaconic Aciduria Type V,3-Methylglutaconic Aciduria Type 5,synonym,Disease or Syndrome,NCIt | |
| 3beta-Hydroxy-5-Cholestenoic Acid Measurement,3beta-Hydroxy-5-Cholestenoic Acid Measurement,standard,Laboratory Procedure,NCIt | |
| 4-Beta-Hydroxy Cholesterol to Total Cholesterol Ratio Measurement,4-Beta-Hydroxycholesterol to Total Cholesterol Ratio Measurement,synonym,Laboratory Procedure,NCIt | |
| 4-Hydroxymidazolam Measurement,4-Hydroxymidazolam Measurement,standard,Laboratory Procedure,NCIt | |
| 4-HNE,4-Hydroxynonenal Measurement,synonym,Laboratory Procedure,NCIt | |
| 4-Hydroxytestosterone Measurement,4-Hydroxytestosterone Measurement,standard,Laboratory Procedure,NCIt | |
| "47,XXX","47,XXX Syndrome",synonym,Disease or Syndrome,NCIt | |
| 50 Percent Cell Culture Infective Dose,50 Percent Cell Culture Infective Dose,standard,Quantitative Concept,NCIt | |
| 50% embryo infective dose,50 Percent Embryo Infective Dose,synonym,Quantitative Concept,NCIt | |
| 50 Percent Embryo Infective Dose per Dose,50 Percent Embryo Infective Dose per Dose,standard,Quantitative Concept,NCIt | |
| EID 50/mL,50 Percent Embryo Infective Dose per Milliliter,synonym,Quantitative Concept,NCIt | |
| 50 Percent Neutralization Endpoint Titer,50 Percent Neutralization Endpoint Titer,standard,Quantitative Concept,NCIt | |
| 50% Tissue Culture Infective Dose,50 Percent Tissue Culture Infective Dose,synonym,Quantitative Concept,NCIt | |
| 6-Monoacetylmorphine Measurement,6-Monoacetylmorphine Measurement,standard,Laboratory Procedure,NCIt | |
| 6-Alpha Hydroxytetrahydro-11-Dehydrocorticosterone,6a OH-tetrahydro-11-DeH-Corticosterone Measurement,synonym,Laboratory Procedure,NCIt | |
| 7-Ketocholesterol Measurement,7-Ketocholesterol Measurement,standard,Laboratory Procedure,NCIt | |
| 7 alpha-Hydroxy-4-cholesten-3-one Measurement,7-alpha-Hydroxy-4-cholesten-3-one Measurement,synonym,Laboratory Procedure,NCIt | |
| "7alpha,25-Dihydroxycholesterol Measurement","7alpha,25-Dihydroxycholesterol Measurement",standard,Laboratory Procedure,NCIt | |
| "7alpha,27-Dihydroxycholesterol","7alpha,27-Dihydroxycholesterol Measurement",synonym,Laboratory Procedure,NCIt | |
| 7beta-Hydroxycholesterol Measurement,7beta-Hydroxycholesterol Measurement,standard,Laboratory Procedure,NCIt | |
| 90% Endpoint Protection Titer,90 Percent Neutralization Endpoint Titer,synonym,Quantitative Concept,NCIt | |
| A Proliferation-Inducing Ligand Measurement,A Proliferation-Inducing Ligand Measurement,standard,Laboratory Procedure,NCIt | |
| AB-PINACA,AB-PINACA Measurement,synonym,Laboratory Procedure,NCIt | |
| ABO Hemolytic Disease of the Newborn,ABO Hemolytic Disease of the Newborn,standard,Disease or Syndrome,NCIt | |
| ADB-PINACA,ADB-PINACA Measurement,synonym,Laboratory Procedure,NCIt | |
| AIDS-Related Cervical Carcinoma,AIDS-Related Cervical Carcinoma,standard,Neoplastic Process,NCIt | |
| AIDS-Related Cervical Kaposi's Sarcoma,AIDS-Related Cervical Kaposi Sarcoma,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Diffuse Large Cell Lymphoma,AIDS-Related Diffuse Large Cell Lymphoma,standard,Neoplastic Process,NCIt | |
| AIDS Associated Diffuse Small Cleaved Cell Lymphoma,AIDS-Related Diffuse Small Cleaved Cell Lymphoma,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Disorder,AIDS-Related Disorder,standard,Disease or Syndrome,NCIt | |
| AIDS-Related Gastric Kaposi's Sarcoma,AIDS-Related Gastric Kaposi Sarcoma,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Hodgkin Lymphoma,AIDS-Related Hodgkin Lymphoma,standard,Neoplastic Process,NCIt | |
| AIDS Associated Immunoblastic Lymphoma,AIDS-Related Immunoblastic Lymphoma,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Lymphoblastic Lymphoma,AIDS-Related Lymphoblastic Lymphoma,standard,Neoplastic Process,NCIt | |
| AIDS-Related Malignant Anal Tumor,AIDS-Related Malignant Anal Neoplasm,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Non-Hodgkin Lymphoma of the Cervix,AIDS-Related Non-Hodgkin Lymphoma of the Cervix,standard,Neoplastic Process,NCIt | |
| AIDS-Related Oral Mucosa Plasmablastic Lymphoma,AIDS-Related Oral Cavity Plasmablastic Lymphoma,synonym,Neoplastic Process,NCIt | |
| AIDS-Related Primary Central Nervous System Lymphoma,AIDS-Related Primary Central Nervous System Lymphoma,standard,Neoplastic Process,NCIt | |
| ALK Protein,ALK Protein Measurement,synonym,Laboratory Procedure,NCIt | |
| ALK-Positive Large B-Cell Lymphoma,ALK-Positive Large B-Cell Lymphoma,standard,Neoplastic Process,NCIt | |
| ALK-RCC,ALK-Rearranged Renal Cell Carcinoma,synonym,Neoplastic Process,NCIt | |
| AM694 N-5-hydroxypentyl Measurement,AM694 N-5-hydroxypentyl Measurement,standard,Laboratory Procedure,NCIt | |
| AP-M Negative,ANPEP Negative,synonym,Finding,NCIt | |
| ASPH-Positive Neoplastic Cells Present,ASPH-Positive Neoplastic Cells Present,standard,Finding,NCIt | |
| A-T Mutated Deficient Tumor,ATM Deficient Tumor,synonym,Finding,NCIt | |
| ATRX Negative,ATRX Negative,standard,Finding,NCIt | |
| AUC All Norm by BMI,AUC All Normalized by Body Mass Index,synonym,Quantitative Concept,NCIt | |
| AUC All Normalized by Surface Area,AUC All Normalized by Surface Area,standard,Quantitative Concept,NCIt | |
| AUC All Norm by WT,AUC All Normalized by Weight,synonym,Quantitative Concept,NCIt | |
| AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose,AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose,standard,Quantitative Concept,NCIt | |
| AUC Infinity Obs Norm by BMI,AUC Infinity Observed Normalized by Body Mass Index,synonym,Quantitative Concept,NCIt | |
| AUC Infinity Observed Normalized by Weight,AUC Infinity Observed Normalized by Weight,standard,Quantitative Concept,NCIt | |
| AUC Infinity Pred Norm by BMI,AUC Infinity Predicted Normalized by Body Mass Index,synonym,Quantitative Concept,NCIt | |
| AUC Infinity Predicted Normalized by Weight-Adjusted Dose,AUC Infinity Predicted Normalized by Weight-Adjusted Dose,standard,Quantitative Concept,NCIt | |
| AUC Over Dosing Interval Norm by SA,AUC Over Dosing Interval Normalized by Surface Area,synonym,Quantitative Concept,NCIt | |
| AUC Over Dosing Interval Normalized by Weight,AUC Over Dosing Interval Normalized by Weight,standard,Quantitative Concept,NCIt | |
| AUC Over Dosing Interval Norm by Dose per Body Weight,AUC Over Dosing Interval Normalized by Weight-Adjusted Dose,synonym,Quantitative Concept,NCIt | |
| AUC from T1 to T2 Normalized by Surface Area,AUC from T1 to T2 Normalized by Surface Area,standard,Quantitative Concept,NCIt | |
| AUC from T1 to T2 Norm by Dose per Body Weight,AUC from T1 to T2 Normalized by Weight-Adjusted Dose,synonym,Quantitative Concept,NCIt | |
| AUMC Dosing to Last Concentration Normalized by Body Mass Index,AUMC Dosing to Last Concentration Normalized by Body Mass Index,standard,Quantitative Concept,NCIt | |
| AUMC to Last Nonzero Conc Norm by Dose,AUMC Dosing to Last Concentration Normalized by Dose,synonym,Quantitative Concept,NCIt | |
| AUMC Dosing to Last Concentration Normalized by Surface Area,AUMC Dosing to Last Concentration Normalized by Surface Area,standard,Quantitative Concept,NCIt | |
| AUMC Infinity Obs Norm by Dose,AUMC Infinity Observed Normalized by Dose,synonym,Quantitative Concept,NCIt | |
| AUMC Infinity Observed Normalized by Surface Area,AUMC Infinity Observed Normalized by Surface Area,standard,Quantitative Concept,NCIt | |
| AUMC Infinity Pred Norm by Dose,AUMC Infinity Predicted Normalized by Dose,synonym,Quantitative Concept,NCIt | |
| AUMC Infinity Predicted Normalized by Weight,AUMC Infinity Predicted Normalized by Weight,standard,Quantitative Concept,NCIt | |
| AUMC Over Dosing Interval Norm by BMI,AUMC Over Dosing Interval Normalized by Body Mass Index,synonym,Quantitative Concept,NCIt | |
| AUMC Over Dosing Interval Normalized by Dose,AUMC Over Dosing Interval Normalized by Dose,standard,Quantitative Concept,NCIt | |
| AUMC Over Dosing Interval Norm by SA,AUMC Over Dosing Interval Normalized by Surface Area,synonym,Quantitative Concept,NCIt | |
| AURC All Normalized by Body Mass Index,AURC All Normalized by Body Mass Index,standard,Quantitative Concept,NCIt | |
| AURC All Norm by Dose,AURC All Normalized by Dose,synonym,Quantitative Concept,NCIt | |
| AURC All Normalized by Surface Area,AURC All Normalized by Surface Area,standard,Quantitative Concept,NCIt | |
| AURC All Norm by WT,AURC All Normalized by Weight,synonym,Quantitative Concept,NCIt | |
| AURC Dosing to Last Concentration Normalized by Body Mass Index,AURC Dosing to Last Concentration Normalized by Body Mass Index,standard,Quantitative Concept,NCIt | |
| AURC Dosing to Last Conc Norm by WT,AURC Dosing to Last Concentration Normalized by Weight,synonym,Quantitative Concept,NCIt |